Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Monday, December 27, 2010
Potential New Treatments for Hepatitis B and Tuberculosis
Working with cultures in his lab, Rakesh Kumar and his colleagues have discovered a new class of drugs for hepatitis B that does three important things: it is effective against the normal strain of the hepatitis B virus, it is effective against the drug-resistant strain and it isn't toxic to healthy cells. He says no one else in the world has identified this class of drugs. These new drugs could be used in combination with other hepatitis B drugs on the market – at the same time, by themselves or one after the other.